Ultralife Corp (ULBI) Reports a net loss for Q4 FY25
Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line…
Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line…
Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss…
Apyx Medical Corporation (APYX), an energy technology company that designs and manufactures electrosurgical equipment and medical devices, reported fourth ...
**BREAKING: Esperion Therapeutics Reports Q4 2025 Earnings Miss**
**Tenax Therapeutics Reports Q4 2025 Results**
Legend Biotech Corporation (LEGN) reported Q4 2025 adjusted earnings of $0.01 per share. No consensus estimate was available for comparison.…
**BREAKING: Esperion Therapeutics Reports Q4 2025 Results**
**BREAKING: Apyx Medical Corporation Reports Q4 2025 Results**
Q32 Bio Inc. (QTTB) reported Q4 2025 adjusted earnings of $3.65 per share. No consensus estimate was available for comparison.…